Surdykowski Andrew J 4
4 · Intercontinental Exchange, Inc. · Filed Mar 2, 2026
Research Summary
AI-generated summary of this filing
ICE General Counsel Andrew Surdykowski Exercises Options, Sells Shares
What Happened
Andrew J. Surdykowski, General Counsel of Intercontinental Exchange, exercised options to acquire 2,065 shares at $57.31 per share (cost ≈ $118,345) on February 26, 2026. On the same day he sold 4,571 shares in two open-market transactions for aggregate proceeds of about $740,524 (3,099 shares and 1,472 shares). He also gifted 200 shares to a philanthropic organization the same day.
Key Details
- Transaction date: February 26, 2026; Form 4 filed March 2, 2026 (timely filing).
- Option exercise: 2,065 shares acquired at $57.31 each (≈ $118,345).
- Open-market sales: 3,099 shares at $161.71 (≈ $501,144) and 1,472 shares at $162.62 (≈ $239,380); total ≈ $740,524. Price ranges for the aggregated sales are reported in footnotes as $161.37–$162.22 and $162.42–$162.87.
- Gift: 200 shares donated to a philanthropic organization (no proceeds).
- Shares owned after transaction (reported aggregate): 40,807 shares of common stock plus 5,734 unvested RSUs and 1,440 PSUs for which the performance period has been satisfied (see footnotes for vesting schedules and outstanding performance awards).
- Notable footnotes: the sales were effected pursuant to a Rule 10b5-1 trading plan effective Nov 25, 2025; price breakdowns for the sales are available on request; certain PSUs/awards vest and will be reported when satisfied. Options involved are reported as fully vested.
Context
This filing shows an option exercise coupled with contemporaneous open-market sales and a charitable gift. The exercise and sales were carried out under a pre-established 10b5-1 trading plan (per footnote), which is a common mechanism executives use to schedule trades in advance. Gifts to charity are not indicative of market sentiment. The filing is factual reporting of transactions and does not by itself reveal the insider’s motivations.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-02-26$57.31/sh+2,065$118,345→ 52,752 total - Sale
Common Stock
[F1][F2]2026-02-26$161.71/sh−3,099$501,144→ 49,653 total - Sale
Common Stock
[F1][F3]2026-02-26$162.62/sh−1,472$239,380→ 48,181 total - Gift
Common Stock
[F4][F5][F6][F7]2026-02-26−200→ 47,981 total - Exercise/Conversion
Employee Stock Option (right to buy) Holding
[F8]2026-02-26−2,065→ 6,194 totalExercise: $57.31Exp: 2027-01-18→ Common Stock (2,065 underlying)
Footnotes (8)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.
- [F2]The price range for the aggregate amount sold by the direct holder is $161.37 - $162.22. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- [F3]The price range for the aggregate amount sold by the direct holder is $162.42 - $162.87. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- [F4]This transaction involved a gift of 200 shares of the issuer's common stock by the reporting person to a philanthropic organization.
- [F5]The common stock number referred in Table I is an aggregate number and represents 40,807 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
- [F6]The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
- [F7]The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
- [F8]These options are fully vested.